M&A Deal Summary |
|
|---|---|
| Date | 2017-11-13 |
| Target | Laboratorio DOSA SA |
| Sector | Life Science |
| Buyer(s) | Grupo Biotoscana |
| Deal Type | Add-on Acquisition |
| Deal Value | 30M USD |
SEARCH BY
Biotoscana Investments SA is a biopharmaceutical group that operates in the fast-growing Latin American region and focuses on rapidly growing market segments such as infectious diseases, oncology and onco-hematology, special treatments, immunology and inflammation, and orphan/rare diseases, among others. Biotoscana Investments was founded in 2011 and is based in Montevideo, Uruguay.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Argentina M&A | 1 of 1 |
| Year: 2017 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
